Related Experiment Video

Updated: May 29, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

Effective design of therapeutic nanovaccines based on tumor neoantigens

Weilin Wang1, Yujia Zhai2, Xiaoye Yang1

  • 1Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|February 1, 2025
PubMed

Insights

Personalized neoantigen vaccines are powerful cancer immunotherapies that stimulate T cell responses and memory. This review explores nanovaccine strategies for optimizing cancer treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Nanotechnology

Background:

  • Neoantigen vaccines represent a potent immunotherapy for personalized cancer treatment.
  • These vaccines elicit tumor-specific T cell responses, offering long-term clinical benefits.

Purpose of the Study:

  • To review the current clinical research on neoantigen nanovaccines.
  • To discuss strategies for optimizing therapeutic outcomes in cancer treatment.

Main Methods:

  • Focus on the application of vectors and adjuvants in neoantigen nanovaccines.
  • Exploration of combinational strategies to enhance vaccine efficacy.

Main Results:

  • Neoantigen vaccines stimulate both existing and new neoantigen-specific T cells.
  • Establishment of a persistent specific memory T cell pool is a key outcome.

Conclusions:

  • Neoantigen nanovaccines hold significant promise for personalized cancer immunotherapy.
  • Optimizing vectors, adjuvants, and combination strategies is crucial for therapeutic success.
Keywords:
NeoantigenNeoantigen nanovaccinesTumor immunotherapyVaccine carriersVaccine delivery

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329